Health

STAT+: Doctors have questions about the Watchman. Boston Scientific has a sales pitch.

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 14/11/2026, 10:07:24 UTC.

Briefings

Boston Scientific continues to promote the Watchman device despite FDA approval delays and significant funding. The company acquired the device over a decade ago and spent hundreds of millions on it, yet it remains the focus of medical-device sales efforts.

Key points

• Boston Scientific committed hundreds of millions of dollars to acquire the Watchman device over a decade ago.
• The device was approved by the FDA for a limited pool of patients after years of debate.

Context

Boston Scientific is a medical-device giant that has faced setbacks but remains committed to the Watchman. The company acquired the device over a decade ago and spent hundreds of millions on it, yet it remains the focus of medical-device sales efforts.

Limitations

Evidence is limited to a single sentence from a source article. No specific dates, numbers, or names of patients are provided. The article does not contain details about the approval process, patient outcomes, or specific sales figures.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 14/11/2026, 10:39:04 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiao3svf3ropgjrooh23rkq3pibc5avy5qr4ymfl5mob76rrsocmea